Abstract:Introduction: Rapid global emergence of antimicrobial resistance led to the failure of many of the antibiotics available in the market. Among multi drug resistant Gram +ve bacteria, methicillin and vancomycin resistant, Staphylococcus aureus strains are leading causes of nosocomial infections involving skin, soft tissues and urinary tract. Therefore, search for new drug targets that are unique to gram positive bacteria is a promising strategy to design novel antibacterial agents. Recently, lipoteichoic acid, a bacterial cell wall glycopolymer, has emerged as a promising and novel target for antimicrobial action. The enzyme, lipoteichoic acid synthase (LtaS) has been recognized as a key enzyme in LTA biosynthesis. Materials & Methods: In the present work, we designed triazole-3-thione based compounds and performed in- silico studies to predict and analyse some commonly used computational tools. The study involved assessment of drug likeliness, prediction and analysis of ADMET parameters by pkCSM and swissADME on the synthesized compounds. The molecular docking study was performed using autodock 4.2 targeting lipoteichoic acid synthase (LtaS) on PDB: 2W5S and interaction of the compounds and inhibition constant were studied. Result & Discussion: All test compounds passed drug likeliness and majority of the compounds had potential to act as enzyme inhibitor or as ligand for G-protein coupled receptors in bioactivity prediction study. The ADMET analysis suggested the compounds suitable for oral administration due to better permeability and intestinal absorption, high tissue distribution, substrate for CYP3A4, CYP2C19 inhibitor, less mutagenic, low MRTD, less hepatotoxicity and none of the compound had potential for fatal ventricular arrythmia. In Docking study, 11 compounds were found to have better affinity with the active site and were able to make stable complexes based upon binding energy data. The compound K24 having thiophene at 5-position and 3-chloro phenyl at 4-position of triazole-3-thione ring was considered as most active compound based on binding energy, inhibition constant value and H-bond interaction with active residue.

Novel 1-Benzoazepine-Derived Michael Acceptor and Its Hetero-Adducts Active Against MRSA

Novel Aminopyrimidinyl Benzimidazoles As Potentially Antimicrobial Agents: Design, Synthesis and Biological Evaluation

Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA-targeting antimicrobial agents

Exploring the potential of bis(thiazol-5-yl)phenylmethane derivatives as novel candidates against genetically defined multidrug-resistant Staphylococcus aureus

Position switch of phenylthiazoles: novel compounds with promising anti-MRSA USA300

Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents

Novel phenylthiazoles with a tert-butyl moiety: promising antimicrobial activity against multidrug-resistant pathogens with enhanced ADME properties

Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker

Anti-MRSA activity of chlorophenyl pyrrolo benzodiazepines compound

Synthesis of Novel Thiazole Derivatives Bearing β-Amino Acid and Aromatic Moieties as Promising Scaffolds for the Development of New Antibacterial and Antifungal Candidates Targeting Multidrug-Resistant Pathogens

Design, synthesis, and evaluation of N1,N3-dialkyldioxonaphthoimidazoliums as antibacterial agents against methicillin-resistant Staphylococcus aureus

Discovery and optimization of tetrahydroacridine derivatives as a novel class of antibiotics against multidrug-resistant Gram-positive pathogens by targeting type I signal peptidase and disrupting bacterial membrane

Synthesis and Antibacterial Evaluation of Novel Small-Molecule Antibacterials of a Reduced Acridine Structure in S. aureus Strains Including MRSA

2-Hydroxypropyl Group Linked Derivatives of Indole Azoles As Potential Multifunctional Antibacterial Candidates for Effectively Inhibiting the Activity of MRSA and Responding Inflammatory Factors.

Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome

Discovery of Novel Pleuromutilin Derivatives as Potent Antibacterial Agents for the Treatment of MRSA Infection

Novel Thiazolylketenyl Quinazolinones as Potential Anti-MRSA Agents and Allosteric Modulator for PBP2a

Novel quinoline/thiazinan-4-one hybrids; design, synthesis, and molecular docking studies as potential anti-bacterial candidates against MRSA

Preliminary structure−activity relationships analysis on N-(3,5-dichlorophenyl)-4,5-dihydronaphtho[1,2-d]thiazol-2-amine, a disruptor of mycobacterial energetics

IN-SILICO ADMET STUDY AND MOLECULAR DOCKING OF TRIAZOLE- 3-THIONE DERIVATIVES TARGETING LIPOTEICHOIC ACID SYNTHASE IN GRAM-POSITIVE BACTERIA

A Novel Promazine Derivative Shows High in vitro and in vivo Antimicrobial Activity Against Staphylococcus aureus